play_arrow
Ozempic Is Science, Not Opinion
-
play_arrow
PLAY EPISODE
Transcript arrow_drop_down
Transcript
Send us Fan Mail
In this episode, I discuss why GLP 1 medications like Ozempic, Wegovy, Mounjaro, and ZepBound should be treated as science, not opinion. Through Melissa’s story, I explain how some patients are dismissed before they ever get a fair discussion about weight loss treatment. I also break down the evidence behind these medications, the prescribing challenges doctors face, and the access barriers that keep many eligible patients from receiving care. The episode closes with practical advice on how patients can ask better questions, seek second opinions, and find physicians who are prepared to support long term obesity treatment.
💡 Start your journey today with Maryland Primary Care & Wellness
Book your consultation: https://www.maryland-primarycare.com/
Episodes
Premium Podcasts
We tackle the health topics no one else wants to touch
—From obesity and high blood pressure
—To emotional eating and medication resistance
—To cultural myths that keep people sick
My mission is to deliver evidence-based truth—no sugarcoating, culture-aware, and guided by medicine.
Popular Links
Dr. Albert E. Takem, M.D. Board-Certified Family Medicine Physician Practicing Clinician with 15+ Years of Experience Author of Intentional Weight Loss: Your 5 Step Guide to Transform Your Body and Recapture Your Glow
Be the first to leave a comment